NCT05186688

Brief Summary

Physical exercise (PE) shows beneficial effects on somatic and psychiatric symptoms. "Braining" is a clinical invention where psychiatric staff exercise together with patients to help patients start and execute PE regularly. In the present study the feasibility of the intervention will be evaluated, how Braining is perceived, and preliminary effects on health and physical activity among patients. The investigators hypothesize that patients' health and physical activity will increase after participation in Braining at the unit. Braining will be implemented at two psychiatric pilot units in Region Stockholm, Sweden. During 6 months patients will be included and treated in 12 weeks PE intervention periods. To measure feasibility patients will answer self-rating questionnaires and be invited to semi structured interviews after receiving the intervention. Health will be measured by physical examination and blood test as well as self-ratings of depression, anxiety, sleep, hypomania, and quality of life before the intervention, every 4 weeks during the intervention, post the intervention, and at follow-up 12 months post the intervention. Physical activity will be rated before, during, after the intervention and at follow-up 12 months post the intervention using International Physical Activity Questionnaires (IPAQ) and Actigraph. All patients that fulfill inclusion criteria at the units will be invited to participate in the study, approximately 50 individuals in total.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 25, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

March 2, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

December 9, 2024

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

December 25, 2021

Last Update Submit

December 4, 2024

Conditions

Keywords

physical exercisemental disorders

Outcome Measures

Primary Outcomes (15)

  • Actigraph GT3x

    Objectively measured physical activity and sedentary time: Total physical activity as counts/day and time spent in sedentary, low, moderate and vigorous intensity as min/day.

    Change from inclusion to follow up 3 months after inclusion

  • Actigraph GT3x

    Objectively measured physical activity and sedentary time: Total physical activity as counts/day and time spent in sedentary, low, moderate and vigorous intensity as min/day.

    At follow up 12 months after intervention.

  • International Physical Activity Questionnaires (IPAQ)

    Self-reported physical activity: Total physical activity as Metabolic Energy Turnover (MET)hours/week and three level categories (low, moderate and high).

    Change from inclusion to follow up 3 months after inclusion

  • International Physical Activity Questionnaires (IPAQ)

    Self-reported physical activity: Total physical activity as Metabolic Energy Turnover (MET)hours/week and three level categories (low, moderate and high).

    At follow up 12 months after intervention.

  • Patient Health Questionnaire 9 (PHQ-9)

    Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.

    Change from inclusion to follow up 3 months after inclusion

  • Patient Health Questionnaire 9 (PHQ-9)

    Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.

    At follow up 12 months after intervention.

  • Alcohol Use Disorders Identification Test AUDIT

    Self rated alcohol use. Minimum value 0, maximum value 32, where higher values indicate higher alcohol use.

    Change from inclusion to follow up 3 months after inclusion

  • Alcohol Use Disorders Identification Test AUDIT

    Self rated alcohol use. Minimum value 0, maximum value 32, where higher values indicate higher alcohol use.

    At follow up 12 months after intervention.

  • Drug Use Disorders Identification Test DUDIT

    Self rated drug use. Minimum value 0, maximum value 44, where higher values indicate higher drug use.

    Change from inclusion to follow up 3 months after inclusion

  • Drug Use Disorders Identification Test DUDIT

    Self rated drug use. Minimum value 0, maximum value 44, where higher values indicate higher drug use.

    At follow up 12 months after intervention.

  • Brunnsviken Brief Quality of Life Questionnaire (BBQ)

    Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.

    Change from inclusion to follow up 3 months after inclusion

  • Brunnsviken Brief Quality of Life Questionnaire (BBQ)

    Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.

    At follow up 12 months after intervention.

  • Acceptability of treatment among patients

    Semi-structured interviews

    At follow up 3-5 months after inclusion

  • The Credibility/Expectancy Questionnaire (CEQ)

    Self rated Credibility of treatment. Minimum value 3, maximum value 27 for each factor, where higher values indicate greater Credibility/Expectancy of the treatment.

    Week 1 of treatment

  • The Client Satisfaction Questionnaire-8 (CSQ-8)

    Self rated satisfaction of treatment. Minimum value 8, maximum value 32 where higher values indicate greater satisfaction with the treatment.

    post treatment, 12 weeks after enrollment

Secondary Outcomes (35)

  • Generalised Anxiety Disorder 7-item scale (GAD-7)

    Change from inclusion to follow up 3 months after inclusion

  • Generalised Anxiety Disorder 7-item scale (GAD-7)

    At follow up 12 months after intervention.

  • Insomnia Severity Index (ISI)

    Change from inclusion to follow up 3 months after inclusion

  • Insomnia Severity Index (ISI)

    At follow up 12 months after intervention.

  • World health organization disability assessment schedule (WHODAS 2.0)

    Change from inclusion to follow up 3 months after inclusion

  • +30 more secondary outcomes

Study Arms (1)

Physical activity

EXPERIMENTAL

Patients are encouraged to participate in physical exercise at the psychiatric unit

Behavioral: Braining

Interventions

BrainingBEHAVIORAL

"Braining" is a clinical invention that helps patients in psychiatry to start and execute physical exercise (PE) regularly in psychiatric care. The core components are basic moderate to vigorous aerobic group training session and motivational work led by the psychiatric staff. Braining is used as add-on treatment to regular psychiatric care and is included in the patient care plan.

Physical activity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient at the psychiatric unit

You may not qualify if:

  • Severe mental disorder such as ongoing mania, psychosis, and conditions when high risk of suicide or high risk of violence available according to the assessment of psychiatric staff at the unit.
  • Medical conditions such as heart or lung disease, infection, abstinence where heart rate-increasing physical activity is considered contraindicated due to Medical reasons.
  • Physical disability that makes it impossible to move independently to the gym and performing the indicated exercise in the training sessions.
  • Mental disability which means that you can not participate in group training.
  • Difficulty speaking or understanding the Swedish language.
  • Ongoing heavy substance use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Region Stockholm, Liljeholmsberget

Stockholm, Sweden

Location

MeSH Terms

Conditions

Mental DisordersMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 25, 2021

First Posted

January 11, 2022

Study Start

March 2, 2022

Primary Completion

July 31, 2022

Study Completion

September 30, 2023

Last Updated

December 9, 2024

Record last verified: 2024-11

Locations